MetaCap

Metagenomi Therapeutics Insider Trades

NASDAQ: MGXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.00+0.0068 (+0.68%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $23.40K
Sales
13 · $33.07K
Shares bought / sold
20.00K / 22.46K
Net activity
Net selling $9,674

Metagenomi Therapeutics insider activity

Over the last 12 months, Metagenomi Therapeutics insiders reported 23 transactions on SEC Form 4: 2 open-market purchases and 13 sales. Insiders bought $23,401 and sold $33,075 worth of stock, for net insider selling of $9,674. The largest seller was Irish Jian, with $12,743 in reported sales.

The most recent filing shows Reid Laurence (Director) buying 19,883 shares at $1.17 on Sep 9, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MGX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

MGX insider transactions

Metagenomi Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 9, 2026Reid LaurenceDirectorBuy117$138.06Form 4
Sep 9, 2026Reid LaurenceDirectorBuy19,883$23.26KForm 4
Sep 8, 2026Wapnick PamelaChief Financial OfficerSale1,911$2.21KForm 4
Sep 8, 2026Irish JianSee RemarksSale2,140$2.48KForm 4
Sep 8, 2026Wein MatthewSee RemarksSale358$414.71Form 4
Jun 5, 2026Wein MatthewSee RemarksSale558$724.84Form 4
Jun 5, 2026Irish JianSee RemarksSale3,737$4.85KForm 4
Jun 5, 2026Wapnick PamelaChief Financial OfficerSale2,884$3.75KForm 4
Apr 1, 2026Wapnick PamelaChief Financial OfficerAward24,000—Form 4
Apr 1, 2026Wein MatthewSee RemarksAward11,000—Form 4
Apr 1, 2026Irish JianSee RemarksAward46,000—Form 4
Mar 5, 2026Wapnick PamelaChief Financial OfficerSale1,581$2.53KForm 4
Mar 5, 2026Irish JianChief Executive OfficerSale1,607$2.57KForm 4
Mar 5, 2026Wein MatthewSee RemarksSale482$771.20Form 4
Dec 5, 2025Irish JianChief Executive OfficerSale1,602$2.84KForm 4
Dec 5, 2025Wapnick PamelaChief Financial OfficerSale1,576$2.79KForm 4
Dec 5, 2025Wein MatthewSee RemarksSale199$352.61Form 4
Dec 5, 2025Thomas Brian C.DirectorSale3,830$6.79KForm 4
Dec 5, 2025Irish JianChief Executive OfficerGift228,462—Form 4
Dec 1, 2025Wapnick PamelaChief Financial OfficerAward120,000$192.00KForm 4
Dec 1, 2025Wein MatthewSee RemarksAward96,000$153.60KForm 4
Dec 1, 2025Irish JianChief Executive OfficerAward211,000$337.60KForm 4
Dec 1, 2025Irish JianChief Executive OfficerAward37,500$60.00KForm 4
Sep 5, 2025Wapnick PamelaChief Financial OfficerSale1,576$2.85KForm 4
Sep 5, 2025Wein MatthewSee RemarksSale199$360.19Form 4
Sep 5, 2025Irish JianChief Executive OfficerSale1,602$2.90KForm 4
Sep 5, 2025Thomas Brian C.DirectorSale2,701$4.89KForm 4
Jun 6, 2025Irish JianSee RemarksSale6,390$11.18KForm 4
Jun 6, 2025Thomas Brian C.Chief Executive OfficerSale10,785$18.87KForm 4
Jun 6, 2025Wapnick PamelaChief Financial OfficerSale1,576$2.76KForm 4
Jun 6, 2025Noonberg Sarah B.Chief Medical OfficerSale5,239$9.17KForm 4
Jun 6, 2025Wein MatthewSee RemarksSale199$348.25Form 4
Apr 1, 2025Wein MatthewSee RemarksAward3,775—Form 4
Apr 1, 2025Wein MatthewSee RemarksAward3,650—Form 4
Apr 1, 2025Thomas Brian C.Chief Executive OfficerAward32,000—Form 4
Apr 1, 2025Wapnick PamelaChief Financial OfficerAward14,000—Form 4
Apr 1, 2025Noonberg Sarah B.Chief Medical OfficerAward14,000—Form 4
Apr 1, 2025Irish JianSee RemarksAward23,000—Form 4
Mar 5, 2025Wein MatthewSee RemarksSale930$1.74KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related